Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Operational Other
confidence 75%
filed 2026-07-15
Item 7.01
NeOnc disclosed receipt of written FDA feedback on the chemistry, manufacturing and controls (CMC) development program for its lead drug candidate NEO212, including specific guidance on formulation, bioavailability studies, and manufacturing requirements. This is a material regulatory milestone for a clinical-stage biotech company that clarifies the path forward for late-stage development of a key asset, though it is not a formal approval or agreement on trial design. The disclosure is operational in nature—relating to drug development strategy and regulatory guidance—rather than financial, governance, or legal.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-15
Item 1.01
AEON Biopharma completed a registered public offering on July 15, 2026, issuing 17,851,599 shares of common stock and 24,837,008 pre-funded warrants with accompanying milestone warrants, raising approximately $12.2 million in net proceeds. The offering represents a substantial dilutive equity issuance to existing shareholders.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-15
Item 5.02
David Weinstein resigned from his position as a member of the Board of Directors, effective July 31, 2026. Weinstein was a founding board member and former CEO who played a significant role during the company's transition to public markets.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-15
Item 6.02
Item 6.02 discloses the termination of Greystone Servicing Company LLC as special servicer and appointment of CWCapital Asset Management LLC (CWCAM) as successor special servicer, effective July 15, 2026. This is a change in a key service provider role under the Pooling and Servicing Agreement governing the mortgage trust. While the filing includes extensive background on CWCAM's qualifications and litigation history, the core event is a governance/administrative change in the trust's service provider structure, which would be material to certificateholders' assessment of the trust's operations and management.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-15
Item 6.02
This Item 6.02 discloses the removal of Greystone Servicing Company LLC as special servicer and appointment of CWCapital Asset Management LLC (CWCAM) as successor special servicer for six mortgage loans representing approximately 29.0% of the BBCMS 2023-5C23 Issuing Entity's assets. While the filing includes extensive background on CWCAM's qualifications and pending litigation, the core event is a change in servicer—a governance/administrative matter affecting the trust's operational structure. This is material to certificateholders as it affects who administers and services the underlying loans, though it is not a departure or appointment of an executive officer of the registrant itself.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-15
Item 5.07
This Item 5.07 disclosure reports the results of the Annual Meeting of Stockholders held on July 9, 2026, where stockholders voted on two matters: (1) election of six directors to the Board, with detailed voting tallies for each nominee showing all were elected, and (2) ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026, which was approved. The disclosure includes complete voting results with votes cast "for," "against," and abstentions for each proposal, which is the core content of a shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Timothy Dugan was appointed to the Board of Directors of Infinity Natural Resources, Inc. effective July 13, 2026, to fill a current vacancy. The Board affirmatively determined his independence, and Dugan brings extensive executive leadership experience spanning four decades in the Appalachian energy industry, including prior roles as CEO and COO at major energy companies.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-15
Item 7.01
The filing announces that Liberty Capital Corporation will issue a press release reporting second quarter 2026 financial results on August 6, 2026, and host a conference call to discuss those results. The press release explicitly states "Liberty Capital Corporation Announces Second Quarter Earnings Release and Conference Call" and references that "Before the open of market trading that day, Liberty Capital will issue a press release reporting such results." This is a disclosure of an upcoming earnings announcement, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Britt Vitalone was appointed to Cheniere's Board of Directors effective July 14, 2026, with assignment to the Audit and Compensation Committees. Vitalone brings 30+ years of executive leadership experience, including his recent role as Executive Vice President and Chief Financial Officer at McKesson Corporation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-14
Item 2.02
EQT discloses preliminary financial results for Q2 2026 under Item 2.02, including a $45 million gain on derivatives and $73 million in net cash settlements received on derivatives. While labeled "preliminary" and subject to change, this constitutes an advance disclosure of quarterly financial results that would materially inform investors' assessment of the company's financial performance and hedging outcomes for the period.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-14
Item 2.02
IBM disclosed selected preliminary financial results for Q2 2026 via CEO letter on July 14, 2026, including revenue of $17.2 billion (up 1%), gross profit margins, pre-tax income margins, cash flow metrics, and diluted EPS of $2.27 GAAP and $2.93 non-GAAP, with a scheduled earnings conference call for July 22, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-14
Item 2.02
Bank of America disclosed second quarter 2026 financial results on July 14, 2026, reporting net income of $9.1 billion and diluted EPS of $1.21, up 34% year-over-year, with revenue of $31.6 billion up 15% year-over-year. The disclosure includes comprehensive quarterly financial results across all business segments and an investor conference call to discuss the results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-14
Item 2.02
Wells Fargo disclosed its second quarter 2026 financial results on July 14, 2026, reporting net income of $6.4 billion and diluted earnings per share of $2.00, with 9% year-over-year revenue growth. The disclosure includes a formal news release, quarterly supplement, and conference call with presentation materials.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-14
Item 2.02
Pentair issued a press release on July 14, 2026 announcing preliminary Q2 2026 earnings results, including sales of approximately $930M, operating income of approximately $165M, and adjusted EPS of approximately $1.12, along with revised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-14
Item 5.02
Nicholas J. Brazis, Executive Vice President and Chief Financial Officer, resigned effective July 10, 2026 to pursue an opportunity at a private company. Robert P. Fishman was appointed as Interim CFO.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 99%
filed 2026-07-14
Item 7.01
The filing discloses the Board of Directors' declaration of a quarterly dividend of $1.0885 per share on Common Stock and preferred shares, payable August 17, 2026. This is a routine but material dividend declaration by a major dividend-paying company with 136 consecutive years of dividend payments and 70 consecutive years of dividend increases, reinforcing P&G's commitment to return cash to shareholders.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-14
Item 1.01
West Pharmaceutical entered into amended and restated technology exchange, cross-license, and distributorship agreements with Daikyo Seiko, Ltd. effective July 14, 2026. These are material commercial agreements governing technology sharing, licensing rights, and distribution arrangements for pharmaceutical packaging products with a 10-year term. While the agreements are substantially similar to prior versions, the formal amendment and restatement of these foundational commercial relationships constitutes a material operational event that does not fit the specific categories of M&A activity, debt issuance, or other defined financial/legal events.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-14
Item 5.02
Van A. Dukeman's employment term as CEO was extended through July 1, 2029, with a material compensatory arrangement consisting of a one-time retention award of restricted stock units valued at $2,067,749.88 vesting on July 1, 2029, plus enhanced severance and benefit protections upon qualifying termination.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-14
Item 8.01
On July 14, 2026, First Busey declared a quarterly cash dividend of $0.26 per share on its outstanding shares of common stock, payable on July 31, 2026.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-14
Item 7.01
The disclosure announces a quarterly cash dividend declaration of $0.52 per share by Lakeland Financial Corporation's Board of Directors, with a specified payment date and record date. This is a routine but material dividend distribution to shareholders, affecting investor returns and capital allocation decisions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-14
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.4453125 per depositary share (representing the Series A Preferred Stock), payable on September 1, 2026, to holders of record as of August 15, 2026. This is a routine but material dividend distribution to preferred shareholders, clearly disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-14
Item 1.01
First Bancorp entered into a definitive Agreement and Plan of Merger and Reorganization to acquire First Carolina Bancshares Corporation in a stock-and-cash transaction valued at approximately $166 million, with consideration of 1,967,017 shares and $40 million in cash. The transaction was unanimously approved by both boards and is expected to close in late Q4 2026 or early Q1 2027, subject to customary closing conditions including shareholder and regulatory approvals, and will substantially expand First Bancorp's South Carolina presence and increase its deposit base by over 50%.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-14
Item 2.02
This is a press release announcing Fastenal's second quarter 2026 financial results, including net sales of $2,386.9 million (14.7% YoY growth), operating income of $501.8 million (21.0% margin), and diluted EPS of $0.33. The disclosure covers quarterly results of operations, gross profit, SG&A expenses, operating income, and cash flow—all core financial metrics that would materially affect a reasonable investor's assessment of the company's performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-14
Item 2.02
Goldman Sachs disclosed its second quarter 2026 earnings results on July 14, 2026, reporting net earnings of $6.628 billion, diluted EPS of $20.98, and net revenues of $20.338 billion, along with a dividend increase to $5.00 per share and $5.36 billion in capital returns.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-14
Item 8.01
The filing discloses that Hawthorn Bancshares, Inc. (HBI) has received all required regulatory approvals as of July 10, 2026, to complete its acquisition of FSC Bancshares, Inc. (FBI) pursuant to an Agreement and Plan of Reorganization entered into on April 29, 2026. The transaction is expected to close in Q3 2026, pending FBI shareholder approval and customary closing conditions. This is a material acquisition event that would significantly affect a reasonable investor's assessment of HBI.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-14
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.25 per share on common shares, payable August 10, 2026. This is a routine but material dividend distribution to shareholders, which affects investor returns and is a standard disclosure for dividend-paying companies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Christian M. Lown was appointed as Executive Vice President and Chief Financial Officer of The Allstate Corporation, effective August 3, 2026. The appointment includes a base salary of $875,000, a sign-on bonus of $2,000,000, and equity grants. Lown brings 25+ years of senior leadership experience in finance and capital markets, including prior CFO roles at CoStar Group, Freddie Mac, and Navient Corporation.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses a change in control agreement entered into with Bradley M. Kool, Executive Vice President and Chief Financial Officer, on July 8, 2026. The agreement specifies severance arrangements (three times base salary plus bonus, COBRA reimbursement for 18 months) and renewal terms tied to board performance evaluations. This is a compensatory arrangement for a named executive officer that would materially affect investor assessment of the company's financial obligations and executive incentives.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-14
EX-99.1
This is an announcement of the timing and logistics for reporting Q2 2026 financial results. Although it does not contain the actual results themselves, it is a press release announcing that TME "will report its unaudited financial results for the second quarter of 2026 before the U.S. market opens on Tuesday, August 11, 2026," along with details of a management webinar to discuss business and financial performance. This is the standard pre-announcement of an earnings release event, which is material to investors as it signals the forthcoming disclosure of quarterly financial performance.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-07-14
The 6-K furnishes the voting results of GeoPark's Annual General Meeting held on July 14, 2026, disclosing the approval of director re-elections (James F. Park, Robert A. Bedingfield, Carlos E. Macellari, Brian F. Maxted, Constantin Papadimitriou, Felipe Bayon), new director elections (Gabriel Gilinski, Dorita Gilinski, Camilo Martinez), and auditor appointment (Ernst & Young Audit S.A.S.) with specific vote tallies for each proposal. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and is material as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-14
Item 1.01
Figure Technology Solutions closed a $600 million offering of 8.500% Senior Notes due 2031 pursuant to an indenture dated July 14, 2026, representing a material creation of direct financial obligations to fund the Kiavi Acquisition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-14
EX-99.1
This press release discloses Q2 2026 operational metrics (TCE earnings, revenue days, spot rates) and a material time-charter contract for the VLCC DHT Jaguar at $75,000/day for 3 years commencing September 2026. While the Q2 figures are backward-looking estimates, the new time-charter agreement with a global energy company is a material operational/commercial event affecting the company's fleet employment strategy and forward cash flows. This does not fit earnings_release (no full financial results) or debt_issuance, but rather represents a significant fleet-employment contract that would affect investor assessment of the company's revenue stability and capital allocation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-14
Item 1.01
Willis Lease Finance Corporation's subsidiary entered into a definitive Purchase and Sale Agreement on July 10, 2026, to acquire a portfolio of 12 commercial aircraft and 13 spare aircraft engines for approximately $379.3 million, expanding the company's lease portfolio and customer base with closing expected in Q3 2026.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-14
EX-99.1
This press release announces the launch of a major 2026 drill program at Frontier's Pine Ridge uranium project, a core operational and strategic initiative. The program involves 36,000 meters of drilling across ~120 holes designed to generate a maiden mineral resource estimate by early 2027. While this is a significant operational milestone for an exploration-stage uranium company, it does not fit the specific event categories (M&A, impairment, litigation, debt, etc.); it is a material exploration and development milestone that would affect investor assessment of the company's progress toward commercialization of its flagship asset.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-07-14
Item 4.01
This is a straightforward auditor change disclosure under Item 4.01. Adeptus Partners, LLC resigned as the Company's independent registered public accounting firm effective July 9, 2026, and the Company is selecting a successor. While the auditor's reports contained no adverse opinions or disagreements, the going-concern language in prior audit reports and the auditor's departure are material to investors assessing the registrant's financial condition and audit quality.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-14
EX-99.1
This exhibit announces the completion of Phase 2 of the No. 3 Shaft modernization program at the Galena Complex, which increases hoisting capacity by 150% (from ~42 stph to 105 stph) and supports planned production growth. The company also discloses two operational incidents: a minor electrical fire at Galena (contained, no injuries, no significant damage) and a regional wildfire near Crescent (no mine damage, brief access disruption). The shaft upgrade is a material operational and strategic milestone supporting the company's growth plans, while the incidents are disclosed as resolved with no material impact on full-year 2026 guidance. This is an operational/strategic business event rather than a discrete financial, governance, or legal event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-14
EX-99.1
This press release announces Nicola Mining's commencement of gold and silver extraction operations at its Dominion Gold Project, with mill feed extraction expected to commence in early July 2026. The disclosure details completion of key infrastructure (operational camp, excavators, drill attachments, haul truck) and hiring of operational crews. This is a material operational milestone for a junior mining company transitioning from exploration/development to production, affecting investor assessment of the company's near-term cash flow generation and strategic positioning.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-14
EX-99.1
This is an exploration update announcing successful completion of drilling and geophysical surveys at Nicola Mining's New Craigmont Copper Project. The disclosure describes technical exploration results (drill hole JT-26-001 confirming porphyry copper target characteristics, Mobile MT geophysical survey, and MMI soil sampling program) that advance the company's exploration model and guide future drilling strategy. While not a discrete M&A, financing, or governance event, this represents a material operational milestone for a junior mining company—the confirmation of a prospective porphyry target and comprehensive technical dataset that positions the company for "aggressive and highly focused exploration program in 2027" would affect a reasonable investor's assessment of exploration success and project value.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 90%
filed 2026-07-14
Item 1.01
Bion Environmental Technologies settled material litigation with Hamstra Builders, Inc. related to construction of the Fair Oaks facility, with mechanics liens and litigation that commenced in April 2025. The settlement involves issuance of a $1.77M convertible note and extension of existing debt maturities, which the CEO characterized as among the company's largest challenges.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-14
Item 5.02
Valerie Greer, Executive Vice President and Chief Commercial Officer, has provided notice of her intent to retire effective February 19, 2027, after nearly four decades in financial services and six years with Bread Financial. The retirement agreement includes severance and benefits, and her departure is material to investors assessing leadership continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-14
Item 5.02
Jon Lin, Chief Business Officer, is separating from employment effective July 18, 2026. The disclosure centers on his departure and associated severance entitlements under the Executive Severance Plan. While a transition plan and future CPO appointment are mentioned, the principal disclosed action is the departure of a named executive officer.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-14
Item 1.01
Alto Neuroscience entered into an underwriting agreement to issue 3,776,436 shares of common stock in a registered direct offering at $26.48 per share, generating approximately $93.9 million in net proceeds. This is a registered equity issuance that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-14
Item 1.01
NextCure entered into a definitive merger agreement with Avere Therapeutics on July 14, 2026, whereby NextCure will acquire Avere in an all-stock transaction. The combined company will operate as Avere Therapeutics, with NextCure stockholders owning approximately 1.21% post-closing, accompanied by a concurrent $320 million private placement financing and expected to close in H2 2026.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-07-14
Item 2.05
NextCure's Board approved a restructuring and workforce reduction plan affecting a substantial majority of the company's workforce during Q3 2026, with expected one-time charges of approximately $1.9 million primarily for employee severance and termination costs.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-14
Item 7.01
The Company announced formation of a special committee of independent directors to evaluate strategic alternatives "which may include a possible transaction involving the Company." The retention of financial advisor Solomon Partners and legal advisor Willkie Farr & Gallagher LLP to assist with the strategic review process signals active consideration of M&A activity. While no transaction has been entered into yet, the initiation of a formal strategic review process evaluating potential acquisitions, mergers, or other transactions is a material disclosure that would affect a reasonable investor's assessment of the registrant's future direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-14
Item 8.01
The filing discloses a material milestone in a merger transaction: on July 13, 2026, the U.S. Department of Justice granted early termination of the Hart-Scott-Rodino Act waiting period for RE/MAX Holdings' proposed merger with The Real Brokerage Inc. This represents a significant regulatory clearance event in the completion of the contemplated transaction, removing a key closing condition. The merger agreement was entered into on April 26, 2026, and this disclosure documents progress toward consummation of the transaction.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-14
The 6-K discloses a material acquisition transaction: Real Brokerage Inc. entered into a Merger Agreement with RE/MAX Holdings on April 26, 2026, and on July 13, 2026, the U.S. Department of Justice granted early termination of the HSR Act waiting period, clearing a major regulatory hurdle toward completion. The filing provides detailed disclosure of the transaction structure, regulatory approvals obtained, and remaining closing conditions, consistent with Item 1.01 (Material Agreements) or Item 2.01 (Completion of Acquisition or Disposition) disclosure obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-14
Item 7.01
This Item 7.01 disclosure concerns a proposed reverse merger transaction between VYNE Therapeutics and Yarrow Bioscience, expected to close approximately July 24, 2026. The filing references a Form S-4 registration statement (File No. 333-294804) containing a proxy statement/prospectus, and the presentation discusses the combined company's strategy, leadership, and clinical pipeline post-transaction. Although styled as a Regulation FD disclosure of an investor presentation, the substance is disclosure of material acquisition activity—specifically a reverse merger that constitutes a change of control.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-14
EX-99.1
MDA Space closed a bought deal offering of 23 million common shares at US$35.60 per share, raising approximately US$819 million in gross proceeds. The company explicitly states it intends to use net proceeds to fund a portion of the purchase price for its acquisition of approximately 70% interest in Collecte Localisation Satellites (CLS). This is a material dilutive equity issuance directly tied to financing a significant M&A transaction, with an over-allotment option for up to 15% additional shares.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-14
Item 2.02
Citigroup disclosed its second quarter 2026 financial results on July 14, 2026, reporting net income of $5.8 billion (up 45% year-over-year) and revenues of $24.8 billion (up 14% year-over-year). The press release, filed as Exhibit 99.1, contains detailed financial statements, segment performance, and CEO commentary on quarterly results. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →